A Randomized, Double Blind, Comparative, Multi-centric, Interventional, Prospective, Clinical study to Evaluate Efficacy & Safety of Topical head application Oil in participants with Stress & Insomnia - NI

Dabur India Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年3月4日

研究概览

暂无简介。

•1. Participants who perceive themselves to be under stress and having a score of between 14 - 24 on the Perceived Stress Scale (PSS)
•2. Participants with insomnia severity more than 7 and less than or equal to 21 on insomnia severity index
•3. Participants willing to follow the procedures as per the study protocol and voluntarily sign an informed consent form.

•1. Participants currently suffering from any known chronic physical, hormonal or psychiatric illness
•2. Participants with uncontrolled diabetes and hypertension
•3. Participants with substance dependence e.g. taking prohibited medications such as opium, cannabis (marijuana) and methamphetamines etc.
•4. Chronic alcoholics and Habitual Tobacco chewers.
•6. Known cases of severe/chronic hepatic or renal disease.
•7. Known case of any active malignancy.
•8. Participants with history of cardiovascular event less than 12 weeks prior to recruitment.
•9. Participants having known chronic, contagious infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV.
•10. Participants using any other investigational drug within 1 month prior to recruitment or participants currently participating in any other Clinical study
•11. Known hypersensitivity to any of the ingredients used in study products
•12. Participants with any current skin or scalp related medical or surgical condition
•13. Pregnant and Lactating females.
•14. Other conditions, which in the opinion of the investigators, make participant unsuitable for enrolment or could interfere with his/her participation and completion of the study

发起方